vs

Side-by-side financial comparison of Hyperfine, Inc. (HYPR) and VALUE LINE INC (VALU). Click either name above to swap in a different company.

VALUE LINE INC is the larger business by last-quarter revenue ($8.3M vs $5.3M, roughly 1.6× Hyperfine, Inc.). VALUE LINE INC runs the higher net margin — 71.4% vs -111.7%, a 183.1% gap on every dollar of revenue. On growth, Hyperfine, Inc. posted the faster year-over-year revenue change (128.0% vs -7.7%). Over the past eight quarters, Hyperfine, Inc.'s revenue compounded faster (26.7% CAGR vs -4.1%).

Hyperfine, Inc. develops and commercializes innovative portable low-field magnetic resonance imaging (MRI) systems for medical diagnostic use. Its solutions deliver accessible, cost-effective imaging for healthcare providers across acute care, rural clinics, pediatric care, and other underserved clinical settings worldwide.

Value Line, Inc. is a publicly traded investment research and financial publishing firm based in New York City. Founded in 1931 by Arnold Bernhard, Value Line is best known for publishing The Value Line Investment Survey, a stock analysis newsletter that tracks approximately 1,700 publicly traded stocks.

HYPR vs VALU — Head-to-Head

Bigger by revenue
VALU
VALU
1.6× larger
VALU
$8.3M
$5.3M
HYPR
Growing faster (revenue YoY)
HYPR
HYPR
+135.8% gap
HYPR
128.0%
-7.7%
VALU
Higher net margin
VALU
VALU
183.1% more per $
VALU
71.4%
-111.7%
HYPR
Faster 2-yr revenue CAGR
HYPR
HYPR
Annualised
HYPR
26.7%
-4.1%
VALU

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
HYPR
HYPR
VALU
VALU
Revenue
$5.3M
$8.3M
Net Profit
$-5.9M
$5.9M
Gross Margin
50.9%
Operating Margin
-144.9%
12.1%
Net Margin
-111.7%
71.4%
Revenue YoY
128.0%
-7.7%
Net Profit YoY
43.1%
14.5%
EPS (diluted)
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HYPR
HYPR
VALU
VALU
Q1 26
$8.3M
Q4 25
$5.3M
$8.6M
Q3 25
$3.4M
$8.6M
Q2 25
$2.7M
$8.4M
Q1 25
$2.1M
$9.0M
Q4 24
$2.3M
$8.8M
Q3 24
$3.6M
$8.9M
Q2 24
$3.6M
$9.0M
Net Profit
HYPR
HYPR
VALU
VALU
Q1 26
$5.9M
Q4 25
$-5.9M
$5.7M
Q3 25
$-11.0M
$6.5M
Q2 25
$-9.2M
$4.0M
Q1 25
$-9.4M
$5.2M
Q4 24
$-10.4M
$5.7M
Q3 24
$-10.3M
$5.9M
Q2 24
$-10.2M
$4.8M
Gross Margin
HYPR
HYPR
VALU
VALU
Q1 26
Q4 25
50.9%
Q3 25
53.8%
Q2 25
49.3%
Q1 25
41.3%
Q4 24
35.6%
Q3 24
52.4%
Q2 24
49.7%
Operating Margin
HYPR
HYPR
VALU
VALU
Q1 26
12.1%
Q4 25
-144.9%
17.7%
Q3 25
-259.5%
17.4%
Q2 25
-355.9%
9.9%
Q1 25
-510.2%
17.4%
Q4 24
-463.8%
19.7%
Q3 24
-300.9%
20.8%
Q2 24
-298.7%
16.5%
Net Margin
HYPR
HYPR
VALU
VALU
Q1 26
71.4%
Q4 25
-111.7%
66.4%
Q3 25
-320.6%
75.1%
Q2 25
-342.2%
47.1%
Q1 25
-440.7%
57.6%
Q4 24
-447.7%
64.3%
Q3 24
-283.4%
66.3%
Q2 24
-279.7%
53.1%
EPS (diluted)
HYPR
HYPR
VALU
VALU
Q1 26
Q4 25
$-0.05
Q3 25
$-0.14
Q2 25
$-0.12
Q1 25
$-0.12
Q4 24
$-0.14
Q3 24
$-0.14
Q2 24
$-0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HYPR
HYPR
VALU
VALU
Cash + ST InvestmentsLiquidity on hand
$35.1M
$92.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.0M
$107.8M
Total Assets
$55.3M
$151.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HYPR
HYPR
VALU
VALU
Q1 26
$92.5M
Q4 25
$35.1M
$86.6M
Q3 25
$21.6M
$33.7M
Q2 25
$25.4M
$67.7M
Q1 25
$33.1M
$52.8M
Q4 24
$37.6M
$22.3M
Q3 24
$45.8M
$30.9M
Q2 24
$53.8M
$4.4M
Stockholders' Equity
HYPR
HYPR
VALU
VALU
Q1 26
$107.8M
Q4 25
$41.0M
$105.5M
Q3 25
$26.9M
$103.0M
Q2 25
$35.1M
$99.7M
Q1 25
$43.1M
$99.0M
Q4 24
$49.0M
$96.7M
Q3 24
$58.3M
$93.9M
Q2 24
$66.8M
$90.8M
Total Assets
HYPR
HYPR
VALU
VALU
Q1 26
$151.0M
Q4 25
$55.3M
$147.9M
Q3 25
$41.5M
$148.2M
Q2 25
$45.2M
$144.5M
Q1 25
$53.4M
$143.6M
Q4 24
$58.9M
$140.0M
Q3 24
$69.4M
$138.6M
Q2 24
$76.6M
$136.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HYPR
HYPR
VALU
VALU
Operating Cash FlowLast quarter
$-5.2M
$5.3M
Free Cash FlowOCF − Capex
$-5.3M
FCF MarginFCF / Revenue
-99.6%
Capex IntensityCapex / Revenue
1.2%
0.0%
Cash ConversionOCF / Net Profit
0.89×
TTM Free Cash FlowTrailing 4 quarters
$-29.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HYPR
HYPR
VALU
VALU
Q1 26
$5.3M
Q4 25
$-5.2M
$3.0M
Q3 25
$-5.6M
$5.6M
Q2 25
$-7.9M
$20.2M
Q1 25
$-9.2M
$6.9M
Q4 24
$-8.4M
$3.1M
Q3 24
$-8.5M
$4.8M
Q2 24
$-9.4M
$17.9M
Free Cash Flow
HYPR
HYPR
VALU
VALU
Q1 26
Q4 25
$-5.3M
Q3 25
$-5.7M
Q2 25
$-8.4M
$20.1M
Q1 25
$-9.7M
$6.8M
Q4 24
$-8.4M
$3.0M
Q3 24
$-8.7M
$4.8M
Q2 24
$-9.5M
$17.9M
FCF Margin
HYPR
HYPR
VALU
VALU
Q1 26
Q4 25
-99.6%
Q3 25
-166.2%
Q2 25
-312.7%
239.2%
Q1 25
-454.9%
75.3%
Q4 24
-360.4%
34.1%
Q3 24
-238.2%
53.7%
Q2 24
-260.4%
199.0%
Capex Intensity
HYPR
HYPR
VALU
VALU
Q1 26
0.0%
Q4 25
1.2%
0.0%
Q3 25
3.8%
0.0%
Q2 25
19.3%
2.1%
Q1 25
22.1%
1.2%
Q4 24
0.3%
0.7%
Q3 24
4.4%
0.0%
Q2 24
2.0%
0.2%
Cash Conversion
HYPR
HYPR
VALU
VALU
Q1 26
0.89×
Q4 25
0.52×
Q3 25
0.86×
Q2 25
5.12×
Q1 25
1.33×
Q4 24
0.54×
Q3 24
0.81×
Q2 24
3.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HYPR
HYPR

Products$4.9M92%
Other$436.0K8%

VALU
VALU

Segment breakdown not available.

Related Comparisons